IGM BIOSCIENCES, INC. (IGMS) Social Stream



IGM BIOSCIENCES, INC. (IGMS): $16.77

0.27 (+1.64%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add IGMS to Watchlist
Sign Up

Industry: Biotech


Ranked

of 395

in industry

IGM Biosciences Inc (IGMS) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering IGM Biosciences Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 8 $119 $82 $99.25 $22.92 333.03%
2021-12-13 8 $126 $51 $86.625 $22.92 277.95%
2021-12-14 8 $126 $38 $78.875 $22.92 244.13%
2021-12-16 8 $126 $38 $74.125 $22.92 223.41%
2022-02-10 8 $126 $25 $72.5 $22.92 216.32%
2022-02-24 8 $90 $25 $64.375 $22.92 180.87%
2022-03-30 8 $90 $25 $63.625 $22.92 177.6%
2022-03-31 8 $74 $30 $56.857 $22.92 148.07%

The Trend in the Analyst Price Target


Over the past 47 weeks, IGMS's average price target has gone down $43.77.

IGMS reports an average of 82% for its upside potential over the past 51 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-25 5 119 77 101.630 60.40 68.26%
2021-08-05 8 119 77 102.130 78.97 29.33%
2021-12-13 8 126 51 86.625 29.25 196.15%
2022-01-31 8 126 25 72.500 17.70 309.6%
2022-03-31 8 74 30 56.857 26.73 112.71%

IGMS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 6 0 2 0 0 8

The Trend in the Broker Recommendations


IGMS's average broker recommendation rating worsened by 0.5 over the prior 23 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • IGM Biosciences Inc's upside potential (average analyst target price relative to current price) is higher than 715.1% of all US stocks.
  • IGMS has a lower variance in analysts' estimates than -595.24% of all US stocks.
  • In the context of Pharmaceutical Products stocks, IGM Biosciences Inc's average analyst price target is greater than 638.98% of them.
  • In the context of Pharmaceutical Products stocks, IGM Biosciences Inc's number of analysts covering the stock is greater than 552.24% of them.

In the Pharmaceutical Products industry, ICPT, HRTX, and HRMY are the three stocks most similar to IGM Biosciences Inc regarding the price target and analyst recommendation information presented here.

Is IGMS a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4482 seconds.